Audistim is a dietary supplement formulated to alleviate the impacts of chronic tinnitus, particularly sleep disturbances and associated anxiety. Its composition is based on ingredients such as melatonin, ginkgo biloba, hawthorn, and tryptophan. Despite its growing popularity, this product does not appear in any official recommendations for good medical practices, raising questions about its limitations and real risks.
Regulatory status of Audistim and level of clinical evidence
A dietary supplement is not a medication. This distinction, often blurred for the general public, changes everything regarding guarantees. Audistim has not received marketing authorization (MA) from the ANSM. It is marketed under the dietary supplement regime, which requires compliance with manufacturing standards but does not demand strict evidence of therapeutic efficacy.
The recommendations from the HAS published in July 2026 on the management of chronic tinnitus do not mention Audistim among the suggested solutions. This does not mean that the product is harmful, but that its level of clinical evidence remains insufficient to be included in a medical reference.
This lack of official recognition should prompt caution, especially when commercial websites present Audistim as a scientifically validated solution. To better understand the truths about the dangers of Audistim, a critical perspective on commercial claims is necessary.
Drug interactions and contraindications of Audistim
The natural character of Audistim’s ingredients does not guarantee total safety. Several components of its formula may interact with common treatments.
Ginkgo biloba and anticoagulants
Ginkgo biloba has vasodilatory and blood-thinning properties. In a person undergoing anticoagulant or antiplatelet treatment, this combination may increase the risk of bleeding. Any patient taking this type of treatment should consult a doctor before using Audistim.
Melatonin and psychotropics
Melatonin, present in the “night” formula, affects the sleep-wake cycle. It can enhance the sedative effect of certain anxiolytics, antidepressants, or hypnotics. The combination of melatonin and psychotropics requires systematic medical advice.
Identified contraindications
Professional sources, including Vidal sheets, mention several situations where Audistim is not recommended:
- Pregnancy and breastfeeding, due to the lack of safety data on the fetus or infant
- Simultaneous use of anticoagulant or antiplatelet treatments, due to ginkgo biloba
- Prolonged use without medical supervision, with a pharmacist reminding that any adverse effect should lead to consulting a doctor
These precautions are rarely highlighted on commercial pages that promote the product.
Reported side effects and vigilance threshold
The side effects observed with Audistim are generally classified as minor: mild digestive disturbances, daytime drowsiness related to melatonin, occasional headaches. The low frequency of these effects contributes to the reassuring image of the product.
The real risk does not lie in these occasional inconveniences. The main danger is delaying appropriate management of tinnitus. Tinnitus can signal an underlying pathology (hearing loss, acoustic neuroma, vascular problem). Relying on a dietary supplement without prior ENT assessment potentially allows a condition that would have benefited from early diagnosis to progress.
Moreover, individual tolerance varies. A supplement well tolerated by the majority may provoke reactions in sensitive or polymedicated individuals. The absence of systematic pharmacovigilance on dietary supplements means that rare adverse effects are likely underreported.
Online purchase of Audistim and counterfeiting risks
The ANSM intensified its actions in 2026 against the online sale of products presented as health supplements but distributed outside the regulated pharmacy circuit. Any product purchased outside a physical pharmacy or an approved site carries an increased risk of counterfeiting.
For Audistim, the concrete risk is twofold:
- Receiving a product whose actual composition differs from the labeling (incorrect dosages, absence of an ingredient, presence of undeclared substances)
- Buying a complete counterfeit, visually identical to the original product but manufactured without quality control
- Losing any recourse in case of adverse effects, as the seller may not be identifiable or located outside French jurisdiction
Prioritizing purchase in a physical pharmacy allows for the benefit of pharmacist advice and product traceability.
Audistim and hearing aids: complementarity or false promise
Audistim is frequently used in conjunction with hearing aids, which remain the first level of management for tinnitus according to audioprosthetists. This complementarity can make sense: the hearing aid acts on sound perception, while Audistim targets secondary consequences (stress, sleep disturbances).
The trap would be to consider Audistim as a substitute for hearing aids or ENT follow-up. A dietary supplement does not restore hearing and does not treat the cause of tinnitus. Its role, if it exists, is limited to supporting quality of life.
Caution remains essential for anyone suffering from persistent tinnitus. A complete hearing assessment, conducted by an ENT specialist, is a prerequisite for any approach, whether medicinal or supplementary. Audistim may find its place in a comprehensive strategy, provided that this place is defined by a healthcare professional and not by a product sheet.